The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Vasim Farooq

Showing 1-20 of 31 articles
The SYNTAX score on its way out or … towards artificial intelligence: part I
Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543A
The SYNTAX score on its way out or … towards artificial intelligence: part II
Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y
May 20, 2020 | 10.4244/EIJ-D-19-00543B
Coronary interventions
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P, Farooq V, Banning A, Escaned J, Wykrzykowska J, Piek J, Dudek D, Ochala A, Hildick-Smith D, Goicolea J, Iñiguez A, Buszman P, Modolo R, Katagiri Y, Kogame N, Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
Coronary interventions
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease
Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P
June 10, 2016 | 10.4244/EIJV12I2A36
Coronary interventions
Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study
Farooq V, Serruys P, Mustafa A, Mamas M, Malik N, Alhous H, El-Omar M, Hendry C, Rana D, Shelton D, Wright P, Narine N, Clarke B, Keavney B, Fath-Ordoubadi F, Fraser D
April 8, 2016 | 10.4244/EIJV11I14A315
Coronary bifurcation treated with the hybrid mini-crush approach: a potential application of three-dimensional optical coherence tomography to optimise stent apposition
Soltani F, Daghem S, Farooq V, El-Omar M
December 20, 2015 | 10.4244/EIJV11I8A187
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data
Bourantas C, Serruys P, Nakatani S, Zhang Y-J, Farooq V, Diletti R, Ligthart J, Sheehy A, van Geuns R, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Rapoza R, Veldhof S, Onuma Y, Garcia-Garcia H
November 20, 2015 | 10.4244/EIJY14M10_06
The triad of residual ischaemia, plaque burden, and plaque vulnerability: a known known?…a known unknown?...or an unknown unknown?
Farooq V, Di Mario C, Serruys P
October 20, 2015 | 10.4244/EIJV11I6A122
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention
Vranckx P, Kalesan B, Stefanini G, Farooq V, Onuma Y, Silber S, de Vries T, Jüni P, Serruys P, Windecker S
June 19, 2015 | 10.4244/EIJV11I2A31
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial
Bourantas C, Farooq V, Zhang Y-J, Muramatsu T, Gogas B, Thuesen L, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Dorange C, Rapoza R, Onuma Y, Garcia-Garcia H, Serruys P
March 20, 2015 | 10.4244/EIJY14M04_11
Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment?
Farooq V, Mamas M, Frase D, El-Omar M, Clarke B, Fath-Ordoubadi F
March 20, 2015 | 10.4244/EIJV10I11A224
Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial
Zhang Y-J, Bourantas C, Muramatsu T, Iqbal J, Farooq V, Diletti R, Campos C, Onuma Y, Garcia-Garcia H, Serruys P
October 20, 2014 | 10.4244/EIJV10I6A118
Lessons from acute and late scaffold failures in the ABSORB EXTEND trial: have we really learned them all?
Farooq V, Fraser D, El-Omar M, Mamas M, Clarke B, Fath-Ordoubadi F
August 19, 2014 | 10.4244/EIJV10I4A73
Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation
Radu M, Räber L, Heo J, Gogas B, Jørgensen E, Kelbæk H, Muramatsu T, Farooq V, Helqvist S, Garcia-Garcia H, Windecker S, Saunamäki K, Serruys P
January 20, 2014 | 10.4244/EIJV9I9A183
The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy
Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein A, van den Brand M, Holmes D, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P
December 27, 2013 | 10.4244/EIJV9I8A170
In vivo assessment of the three-dimensional haemodynamic micro-environment following drug-eluting bioresorbable vascular scaffold implantation in a human coronary artery: fusion of frequency domain optical coherence tomography and angiography
Papafaklis M, Bourantas C, Farooq V, Diletti R, Muramatsu T, Zhang Y-J, Fotiadis D, Onuma Y, Garcia-Garcia H, Michalis L, Serruys P
November 29, 2013 | 10.4244/EIJV9I7A147
Revisiting: “Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients”
Zhang Y-J, Garcia-Garcia H, Farooq V, Bourantas C, Serruys P, Chen S
November 29, 2013 | 10.4244/EIJV9I7A148
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
Gogas B, Bourantas C, Garcia-Garcia H, Onuma Y, Muramatsu T, Farooq V, Diletti R, van Geuns R, De Bruyne B, Chevalier B, Thuesen L, Smits P, Dudek D, Koolen J, Windecker S, Whitbourn R, McClean D, Dorange C, Miquel-Hebert K, Veldhof S, Rapoza R, Ormiston J, Serruys P
October 25, 2013 | 10.4244/EIJV9I6A115
Observations from the CREDO-Kyoto three-vessel disease registry: can one adjust for the unadjustable?
Farooq V, Serruys P
August 23, 2013 | 10.4244/EIJV9I4A68
Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial
Diletti R, Garcia-Garcia H, Bourantas C, van Geuns R, Van Mieghem N, Agostoni P, Muramatsu T, Farooq V, Spencer R, de Schepper J, Pomeranz M, Stella P, Serruys P
May 21, 2013 | 10.4244/EIJV9I1A18

Latest news

NEW ISSUE
State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more
October 20, 2021
STATE OF THE ART
Valve-in-valve TAVI: a practical overview
Giuseppe Tarantini et al.
October 20, 2021
AHEAD OF PRINT
TAVI in younger (<70 years old) patients: the AMTRAC registry
Guy Witberg et al.
October 22, 2021
AHEAD OF PRINT
Impact of LVOT calcification in transfemoral TAVI patients
L. Waldschmidt et al.
October 19, 2021
VIEWPOINT
My Stroke Story
Marco Noc
October 20, 2021
AHEAD OF PRINT
Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial
Hironori Hara et al.
October 22, 2021
AHEAD OF PRINT
Serum caffeine causes adenosine-induced FFR overestimation
Hideaki Tanaka et al.
October 15, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke